Clinical trials
Phase 3 Prostatic Neoplasms trials in Romania
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 3 |
| 2013 | 4 |
| 2015 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Active, not recruiting | 6 |
| Terminated | 4 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 4 |
| Ferring Pharmaceuticals | 4 |
| Aragon Pharmaceuticals, Inc. | 3 |
| AstraZeneca | 2 |
| Ipsen | 2 |
| Sanofi | 2 |
| Active Biotech AB | 1 |
| Celgene | 1 |
| Central European Cooperative Oncology Group | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 27 |
| Bulbo-Spinal Atrophy, X-Linked | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
| Urogenital Neoplasms | 1 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.